US Stock MarketDetailed Quotes

ORMP Oramed Pharmaceuticals

Watchlist

2.300
-0.010-0.43%

Close May 22 16:00 ET

93.45MMarket Cap8.85P/E (TTM)

Oramed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-50.43%1.34M

0.00%674K

0.00%666K

199.00%2.7M

-0.29%681K

0.15%682K

1.35%674K

Operating revenue

--0

-50.43%1.34M

--0

0.00%674K

0.00%666K

199.00%2.7M

-0.29%681K

0.15%682K

1.35%674K

Cost of revenue

Gross profit

Operating expense

-49.57%2.96M

-60.49%17.11M

-62.80%3.88M

-67.39%2.89M

-63.07%4.47M

-50.71%5.87M

227.29%43.3M

28.77%10.42M

30.48%8.87M

118.53%12.09M

Selling and administrative expenses

23.22%1.78M

-48.04%8.14M

-32.86%2.11M

-45.06%1.94M

-9.20%2.64M

-76.21%1.45M

273.53%15.66M

39.80%3.14M

171.70%3.52M

75.00%2.91M

-Selling and marketing expense

--0

-115.51%-287K

--0

-243.20%-663K

-49.47%192K

-68.81%184K

106.12%1.85M

--418K

--463K

--380K

-General and administrative expense

41.17%1.78M

-39.00%8.43M

-22.56%2.11M

-15.09%2.6M

-3.16%2.45M

-77.00%1.26M

319.15%13.81M

21.21%2.73M

136.01%3.06M

52.16%2.53M

Research and development costs

-73.37%1.18M

-67.54%8.97M

-75.73%1.77M

-82.10%957K

-80.16%1.82M

-24.14%4.43M

205.84%27.64M

24.52%7.28M

-2.82%5.35M

137.24%9.18M

Operating profit

43.13%-2.96M

61.16%-15.77M

60.20%-3.88M

64.67%-2.89M

66.80%-3.79M

53.71%-5.21M

-229.37%-40.6M

-31.44%-9.74M

-33.85%-8.19M

-134.53%-11.42M

Net non-operating interest income expense

181.53%4.5M

28.76%4.59M

-44.61%905K

-137.74%-391K

608.00%2.48M

193.57%1.6M

2,214.29%3.56M

344.25%1.63M

110.14%1.04M

34.62%350K

Non-operating interest income

218.60%5.09M

124.63%8.03M

114.00%3.52M

-58.01%435K

608.00%2.48M

193.57%1.6M

2,175.80%3.57M

--1.64M

--1.04M

--350K

Non-operating interest expense

--592K

--2.04M

--1.21M

--826K

----

--0

----

Total other finance cost

----

15,455.56%1.4M

----

800.00%9K

----

Other net income (expense)

2,682.22%16.27M

-659.04%-630K

Gain on sale of security

----

2,682.22%16.27M

----

-659.04%-630K

----

Income before tax

142.48%1.53M

113.51%5.09M

252.20%13.3M

54.09%-3.28M

88.14%-1.31M

66.28%-3.61M

-207.34%-37.66M

-21.57%-8.74M

-27.16%-7.15M

-140.17%-11.07M

Income tax

100K

Net income

142.48%1.53M

113.47%5.09M

252.20%13.3M

54.72%-3.28M

88.14%-1.31M

66.28%-3.61M

-208.15%-37.76M

-21.57%-8.74M

-28.94%-7.25M

-140.17%-11.07M

Net income continuous Operations

142.48%1.53M

113.47%5.09M

252.20%13.3M

54.72%-3.28M

88.14%-1.31M

66.28%-3.61M

-208.15%-37.76M

-21.57%-8.74M

-28.94%-7.25M

-140.17%-11.07M

Minority interest income

99.07%-2K

63.67%-437K

79.27%-40K

67.88%-62K

77.72%-119K

23.67%-216K

-104.94%-1.2M

42.04%-193K

53.83%-193K

-534K

Net income attributable to the parent company

145.24%1.54M

115.11%5.53M

256.10%13.34M

54.36%-3.22M

88.66%-1.19M

67.43%-3.4M

-213.34%-36.56M

-24.66%-8.54M

-35.59%-7.06M

-128.58%-10.53M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

145.24%1.54M

115.11%5.53M

256.10%13.34M

54.36%-3.22M

88.66%-1.19M

67.43%-3.4M

-213.34%-36.56M

-24.66%-8.54M

-35.59%-7.06M

-128.58%-10.53M

Basic earnings per share

150.00%0.04

114.89%0.14

250.00%0.33

55.56%-0.08

88.89%-0.03

70.37%-0.08

-203.23%-0.94

-4.76%-0.22

-5.88%-0.18

-58.82%-0.27

Diluted earnings per share

150.00%0.04

114.89%0.14

250.00%0.33

55.56%-0.08

88.89%-0.03

70.37%-0.08

-203.23%-0.94

-4.76%-0.22

-5.88%-0.18

-58.82%-0.27

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	-50.43%1.34M	0	0	0.00%674K	0.00%666K	199.00%2.7M	-0.29%681K	0.15%682K	1.35%674K
Operating revenue	--0	-50.43%1.34M	--0	--0	0.00%674K	0.00%666K	199.00%2.7M	-0.29%681K	0.15%682K	1.35%674K
Cost of revenue
Gross profit
Operating expense	-49.57%2.96M	-60.49%17.11M	-62.80%3.88M	-67.39%2.89M	-63.07%4.47M	-50.71%5.87M	227.29%43.3M	28.77%10.42M	30.48%8.87M	118.53%12.09M
Selling and administrative expenses	23.22%1.78M	-48.04%8.14M	-32.86%2.11M	-45.06%1.94M	-9.20%2.64M	-76.21%1.45M	273.53%15.66M	39.80%3.14M	171.70%3.52M	75.00%2.91M
-Selling and marketing expense	--0	-115.51%-287K	--0	-243.20%-663K	-49.47%192K	-68.81%184K	106.12%1.85M	--418K	--463K	--380K
-General and administrative expense	41.17%1.78M	-39.00%8.43M	-22.56%2.11M	-15.09%2.6M	-3.16%2.45M	-77.00%1.26M	319.15%13.81M	21.21%2.73M	136.01%3.06M	52.16%2.53M
Research and development costs	-73.37%1.18M	-67.54%8.97M	-75.73%1.77M	-82.10%957K	-80.16%1.82M	-24.14%4.43M	205.84%27.64M	24.52%7.28M	-2.82%5.35M	137.24%9.18M
Operating profit	43.13%-2.96M	61.16%-15.77M	60.20%-3.88M	64.67%-2.89M	66.80%-3.79M	53.71%-5.21M	-229.37%-40.6M	-31.44%-9.74M	-33.85%-8.19M	-134.53%-11.42M
Net non-operating interest income expense	181.53%4.5M	28.76%4.59M	-44.61%905K	-137.74%-391K	608.00%2.48M	193.57%1.6M	2,214.29%3.56M	344.25%1.63M	110.14%1.04M	34.62%350K
Non-operating interest income	218.60%5.09M	124.63%8.03M	114.00%3.52M	-58.01%435K	608.00%2.48M	193.57%1.6M	2,175.80%3.57M	--1.64M	--1.04M	--350K
Non-operating interest expense	--592K	--2.04M	--1.21M	--826K	----	--0	--0	--0	--0	----
Total other finance cost	----	15,455.56%1.4M	----	----	----	----	800.00%9K	----	----	----
Other net income (expense)		2,682.22%16.27M					-659.04%-630K
Gain on sale of security	----	2,682.22%16.27M	----	----	----	----	-659.04%-630K	----	----	----
Income before tax	142.48%1.53M	113.51%5.09M	252.20%13.3M	54.09%-3.28M	88.14%-1.31M	66.28%-3.61M	-207.34%-37.66M	-21.57%-8.74M	-27.16%-7.15M	-140.17%-11.07M
Income tax		0	0	0			100K	0	100K
Net income	142.48%1.53M	113.47%5.09M	252.20%13.3M	54.72%-3.28M	88.14%-1.31M	66.28%-3.61M	-208.15%-37.76M	-21.57%-8.74M	-28.94%-7.25M	-140.17%-11.07M
Net income continuous Operations	142.48%1.53M	113.47%5.09M	252.20%13.3M	54.72%-3.28M	88.14%-1.31M	66.28%-3.61M	-208.15%-37.76M	-21.57%-8.74M	-28.94%-7.25M	-140.17%-11.07M
Minority interest income	99.07%-2K	63.67%-437K	79.27%-40K	67.88%-62K	77.72%-119K	23.67%-216K	-104.94%-1.2M	42.04%-193K	53.83%-193K	-534K
Net income attributable to the parent company	145.24%1.54M	115.11%5.53M	256.10%13.34M	54.36%-3.22M	88.66%-1.19M	67.43%-3.4M	-213.34%-36.56M	-24.66%-8.54M	-35.59%-7.06M	-128.58%-10.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	145.24%1.54M	115.11%5.53M	256.10%13.34M	54.36%-3.22M	88.66%-1.19M	67.43%-3.4M	-213.34%-36.56M	-24.66%-8.54M	-35.59%-7.06M	-128.58%-10.53M
Basic earnings per share	150.00%0.04	114.89%0.14	250.00%0.33	55.56%-0.08	88.89%-0.03	70.37%-0.08	-203.23%-0.94	-4.76%-0.22	-5.88%-0.18	-58.82%-0.27
Diluted earnings per share	150.00%0.04	114.89%0.14	250.00%0.33	55.56%-0.08	88.89%-0.03	70.37%-0.08	-203.23%-0.94	-4.76%-0.22	-5.88%-0.18	-58.82%-0.27
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall